Patient Groups Sue HHS, CMS for 2020 Rule Allowing the Use of Copay Accumulator Programs
FDA Law Blog
SEPTEMBER 8, 2022
As it stands, the rule allows insurers and pharmacy benefit managers (PBMs) to broadly use copay accumulator programs, which have long been criticized by patient advocacy groups as padding insurers’ pockets while leaving patients high and dry. 156.130(h) to explicitly allow insurers to broadly use copay accumulator programs.
83 
Let's personalize your content